Researchers discover gene that blocks HIV

February 29, 2008

A team of researchers at the University of Alberta has discovered a gene that is able to block HIV, and in turn prevent the onset of AIDS.

Stephen Barr, a molecular virologist in the Department of Medical Microbiology and Immunology, says his team has identified a gene called TRIM22 that can block HIV infection in a cell culture by preventing the assembly of the virus.

"When we put this gene in cells, it prevents the assembly of the HIV virus," said Barr, a postdoctoral fellow. "This means the virus cannot get out of the cells to infect other cells, thereby blocking the spread of the virus."

Barr and his team also prevented cells from turning on TRIM22 - provoking an interesting phenomenon: the normal response of interferon, a protein that co-ordinates attacks against viral infections, became useless at blocking HIV infection.

"This means that TRIM22 is an essential part of our body's ability to fight off HIV. The results are very exciting because they show that our bodies have a gene that is capable of stopping the spread of HIV."

One of the greatest challenges in battling HIV is the virus' ability to mutate and evade medications. Antiretroviral drugs introduced during the late 1990s interfere with HIV's ability to produce new copies of itself - and even they are beneficial, the drugs are unable to eradicate the virus. Barr and his team have discovered a gene that could potentially do the job naturally.

"There are always newly emerging drug-resistant strains of HIV so the push has been to develop more natural means of blocking the virus. The discovery of this gene, which is natural in our cells, might provide a different avenue," said Barr. "The gene prevents the assembly of the virus so in the future the idea would be to develop drugs or vaccines that can mimic the effects of this gene."

"We are currently trying to figure out why this gene does not work in people infected with HIV and if there is a way to turn this gene on in those individuals," he added. "We hope that our research will lead to the design of new drugs, or vaccines that can halt the person-to-person transmission of HIV and the spread of the virus in the body, thereby blocking the onset of AIDS."

The researchers are now investigating the gene's ability to battle other viruses.

Barr's research is funded by the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council and the Alberta Heritage Foundation for Medical Research. The findings are published in the Public Library of Science Pathogens.

Source: University of Alberta

Explore further: Mutational tug of war over HIV's disease-inducing potential

Related Stories

Mutational tug of war over HIV's disease-inducing potential

August 23, 2016

A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

How a nasty, brain-eating parasite could help us fight cancer

August 26, 2016

We've known since the turn of the 20th century that some infectious diseases are a major risk for developing specific cancers. More worryingly, about one-sixth of cancers worldwide are attributable to infectious agents. Globally, ...

Dormant copies of HIV mostly defective, new study shows

August 8, 2016

After fully sequencing the latent HIV "provirus" genomes from 19 people being treated for HIV, scientists at Johns Hopkins Medicine report that even in patients who start treatment very early, the only widely available method ...

A macaque model of HIV infection

June 2, 2016

Researchers have taken a major step toward developing a better animal model of human AIDS. Such a model could greatly improve researchers' ability to evaluate potential strategies for preventing and treating the disease.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

MikeMarianiMD,FAAP
1 / 5 (1) Mar 01, 2008
"...why this gene does not work in people with HIV..." This remark renders the research findings utterly trivial
Jim_
5 / 5 (1) Mar 01, 2008
Mike: I believe you are misreading that comment, it is not stating that the (anti-HIV) gene is ineffective in people, it is stating that people with HIV have an inactive ("not work") TRIM22 gene.
gmurphy
not rated yet Mar 03, 2008
I think ye have both hit on the most important aspect of this article, here appears to be a factor which is effective against HIV, yet, the article does not address its ability to actually treat people with the disease, which is of course, what we really want to know.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.